Office Building

Portfolio

 New Rhein Fund 18 has invested in five companies developing proprietary drug/ device platforms for the treatment of COPD, BPH, COVID-19, etc. 

Sayvaa
Pharma
Screen%20Shot%202020-10-12%20at%2011.14_

Past Deals

Prior investments have included medicines for Alzheimer’s disease, ophthalmic disorders, respiratory disease, and molecular oncology diagnostics.  

chase pharma logo.jfif
Chase 
Pharmaceuticals
novagali logo.jfif

Novagali was a French ophthalmology

 company developing products for Dry Eye Disease and Glaucoma.  The company was acquired by Santen for $139M in 2011.

+1 215 419 7830

  • LinkedIn